Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02631070
Brief Title: A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MEDALIST)

First Submitted : November 10, 2015
First Submitted that Met QC Criteria : December 11, 2015
First Posted : December 15, 2015 (Estimate)

Results First Submitted : May 1, 2020
Results First Submitted that Met QC Criteria : May 1, 2020
Results First Posted : May 22, 2020

Certification/Extension First Submitted : May 16, 2018
Certification/Extension First Submitted that Met QC Criteria : May 16, 2018
Certification/Extension First Posted : May 18, 2018

Last Update Submitted that Met QC Criteria : February 16, 2021
Last Update Posted : March 11, 2021